Also came with the MIM hive off. An if only stock with respect to MIM. Still very scary with very limited updates in the turbulent environment. Quarterly update this month?
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%